Search Results - "Bast, M."

Stromal Gene Signatures in Large-B-Cell Lymphomas by Lenz, G, Wright, G, Dave, S.S, Xiao, W, Powell, J, Zhao, H, Xu, W, Tan, B, Goldschmidt, N, Iqbal, J, Vose, J, Bast, M, Fu, K, Weisenburger, D.D, Greiner, T.C, Armitage, J.O, Kyle, A, May, L, Gascoyne, R.D, Connors, J.M, Troen, G, Holte, H, Kvaloy, S, Dierickx, D, Verhoef, G, Delabie, J, Smeland, E.B, Jares, P, Martinez, A, Lopez-Guillermo, A, Montserrat, E, Campo, E, Braziel, R.M, Miller, T.P, Rimsza, L.M, Cook, J.R, Pohlman, B, Sweetenham, J, Tubbs, R.R, Fisher, R.I, Hartmann, E, Rosenwald, A, Ott, G, Muller-Hermelink, H.-K, Wrench, D, Lister, T.A, Jaffe, E.S, Wilson, W.H, Chan, W.C, Staudt, L.M

“…In this study, microarrays of stromal-cell RNA showed one signature that correlated with extracellular-matrix deposition and monocytic infiltration and another…”
Get full text

Evidence of Partial Seniority Conservation in the $\pi{g}_{9/2}$ Shell for the $N=50$ Isotones by Pérez-Vidal, R.M., Gadea, A., Domingo-Pardo, C., Gargano, A., Valiente-Dobón, J.J., Clément, E., Lemasson, A., Coraggio, L., Siciliano, M., Szilner, S., Bast, M., Braunroth, T., Collado, J., Corina, A., Dewald, A., Doncel, M., Dudouet, J., de France, G., Fransen, C., González, V., Hüyük, T., Jacquot, B., John, P.R., Jungclaus, A., Kim, Y.H., Korichi, A., Labiche, M., Lenzi, S., Li, H., Ljungvall, J., López-Martens, A., Mengoni, D., Michelagnoli, C., Müller-Gatermann, C., Napoli, D.R., Navin, A., Quintana, B., Ramos, D., Rejmund, M., Sanchis, E., Simpson, J., Stezowski, O., Wilmsen, D., Zielińska, M., Boston, A.J., Barrientos, D., Bednarczyk, P., Benzoni, G., Birkenbach, B., Boston, H.C., Bracco, A., Cederwall, B., Cullen, D.M., Didierjean, F., Eberth, J., Gottardo, A., Goupil, J., Harkness-Brennan, L.J., Hess, H., Judson, D.S., Kaşkaş, A., Korten, W., Leoni, S., Menegazzo, R., Million, B., Nyberg, J., Podolyak, Zs, Pullia, A., Ralet, D., Recchia, F., Reiter, P., Rezynkina, K., Salsac, M.D., Şenyiğit, M., Sohler, D., Theisen, Ch, Verney, D.

“…The reduced transition probabilities for the $4^+_1 \to 2^+_1$ and $2^+_1 \to 0^+_1$ transitions in $^{92}$Mo and $^{94}$Ru and for the $4^+_1 \to 2^+_1$ and…”
Get full text

Accessing tens-to-hundreds femtoseconds nuclear state lifetimes with low-energy binary heavy-ion reactions by Ciemała, M., Ziliani, S., Crespi, F. C. L., Leoni, S., Fornal, B., Maj, A., Bednarczyk, P., Benzoni, G., Bracco, A., Boiano, C., Bottoni, S., Brambilla, S., Bast, M., Beckers, M., Braunroth, T., Camera, F., Cieplicka-Oryńczak, N., Clément, E., Coelli, S., Dorvaux, O., Erturk, S., De France, G., Fransen, C., Goldkuhle, A., Grębosz, J., Harakeh, M. N., Iskra, Ł. W., Jacquot, B., Karpov, A., Kicińska-Habior, M., Kim, Y.-H., Kmiecik, M., Lemasson, A., Lenzi, S. M., Lewitowicz, M., Li, H., Matea, I., Mazurek, K., Michelagnoli, C., Matejska-Minda, M., Million, B., Müller-Gatermann, C., Nanal, V., Napiorkowski, P., Napoli, D. R., Palit, R., Rejmund, M., Schmitt, Ch, Stanoiu, M., Stefan, I., Vardaci, E., Wasilewska, B., Wieland, O., Ziębliński, M., Zielińska, M.

“…A novel Monte Carlo technique has been developed to determine lifetimes of excited states in the tens-to-hundreds femtoseconds range in products of low-energy…”
Get full text

Lifetime measurement of excited states in 46Ti by Goldkuhle, A., Fransen, C., Dewald, A., Arnswald, K., Bast, M., Beckers, M., Blazhev, A., Braunroth, T., Hackenberg, G., Häfner, G., Litzinger, J., Jolie, J., Müller-Gatermann, C., von Spee, F., Warr, N., Werner, D., Zell, K. O.

“… The level lifetimes of the yrast 2 1 + , 4 1 + and 6 1 + states and an upper limit of the lifetime of the 8 1 + state in 46 Ti have been measured with high…”
Get full text

SURVIVAL FOLLOWING FIRST RELAPSE IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA by Karmali, R., Donovan, A., Wagner‐Johntson, N., Messmer, M., Mehta, A., Anderson, J. K., Reddy, N., Kovach, A. E., Landsburg, D. J., Glenn, M., Inwards, D. J., Ristow, K., Lansigan, F., Kaplan, J. B., Caimi, P. B., Rajguru, S., Evens, A., Klein, A., Umyarova, E., Amengual, J. E., Lue, J. K., Diefenbach, C., Epperla, N., Barta, S. K., Hernandez‐Ilizaliturri, F. J, Handorf, E., Villa, D., Gerrie, A. S., Li, S., Mederios, J., Wang, M., Cohen, J., Calzada, O., Churnetski, M., Hill, B., Sawalha, Y., Gerson, J. N., Kothari, S., Vose, J. M., Bast, M., Fenske, T. S., Narayana Rao Gari, S., Maddocks, K. J., Bond, D., Bachanova, V., Kolla, B., Chavez, J., Shah, B.

Get full text

PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK‐POSITIVE ANAPLASTIC LARGE‐CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES by Sibon, D., Nguyen, D., Schmitz, N., Suzuki, R., Feldman, A.L., Gressin, R., Lamant, L., Weisenburger, D., Nakamura, S., Ziepert, M., Maurer, M.J., Bast, M., Armitage, J.O., Vose, J.M., Tilly, H., Jais, J.P., Savage, K.J.

Get full text

Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism by Mahy, P., Geets, X., Lonneux, M., Levêque, P., Christian, N., De Bast, M., Gillart, J., Labar, D., Lee, J., Grégoire, V.

“…Purpose The aim of this study was to assess the pharmacokinetics, biodistribution and metabolism of [ 18 F]EF3, a labelled 2-nitroimidazole hypoxia marker, in…”
Get full text

Plant diversity and tree responses following contrasting disturbances in boreal forest by Peltzer, Duane A, Bast, Marcy L, Wilson, Scott D, Gerry, Ann K

“…We determined the abundance and diversity of vascular plants in seven types of disturbance in mixed-wood boreal forest. Disturbance treatments included…”
Get full text

440 poster A GRADIENT-BASED SEGMENTATION METHOD FOR FDG-PET BASED GTV DELINEATION: CLINICAL VALIDATION IN NSCLC by Wanet, M, Lee, J.A, Weynand, B, de Bast, M, Poncelet, A, Lacroix, V, Coche, E, Grégoire, V, Geets, X

Get full text

Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis by Mahy, P, De Bast, M, Gillart, J, Labar, D, Grégoire, V

“…In the framework of the preclinical validation of the hypoxic tracer [(18)F]EF3, a comparison was performed between uptake of [(18)F]EF3 and EF5 adducts…”
Get full text

Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3 by Mahy, P., De Bast, M., Leveque, P.H., Gillart, J., Labar, D., Marchand, J., Gregoire, V.

“…The 2-nitroimidazole derivative 2-(2-nitroimidazol-1-yl)-<N<-(3,3,3-trifluoropropyl)acetamide (EF3) is a marker which forms adducts into hypoxic cells…”
Get full text

Primary Mediastinal Large B-Cell Lymphoma: A Clinicopathologic Study of 43 Patients From the Nebraska Lymphoma Study Group by ABOU-ELELLA, A. A, WEISENBURGER, D. D, VOSE, J. M, KOLLATH, J. P, LYNCH, J. C, BAST, M. A, BIERMAN, P. J, GREINER, T. C, CHAN, W. C, ARMITAGE, J. O

“…To investigate whether primary mediastinal large B-cell lymphoma (PMLBL) is a distinct clinicopathologic entity with a more aggressive course than other…”
Get full text

Prognostic Value of Cellular Proliferation and Histologic Grade in Follicular Lymphoma by Martin, Anita R., Weisenburger, Dennis D., Chan, Wing C., Ruby, Elizabeth I., Anderson, James R., Vose, Julie M., Bierman, Philip J., Bast, Martin A., Daley, Donald T., Armitage, James O.

“…The clinical usefulness of histologic grading in follicular lymphoma (FL) is controversial and is further compromised by the subjective nature and poor…”
Get full text

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma by Stewart, D A, Vose, J M, Weisenburger, D D, Anderson, J R, Ruby, E I, Bast, M A, Bierman, P J, Kessinger, A, Armitage, J O

“…Although mantle cell lymphoma (MCL) is a distinct disease entity with well described clinical and pathological features, little information exists regarding…”
Get more information

Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma by Yan, Y, Chan, W C, Weisenburger, D D, Anderson, J R, Bast, M A, Vose, J M, Bierman, P J, Armitage, J O

“…We studied the effect of morphology and extent of bone marrow (BM) infiltrate on the survival of patients with diffuse aggressive B-cell non-Hodgkin's lymphoma…”
Get more information

Occurrence of the t(2;5)(p23;q35) in Non-Hodgkin's Lymphoma by Weisenburger, Dennis D., Gordon, Bruce G., Vose, Julie M., Bast, Martin A., Chan, Wing C., Greiner, Timothy C., Anderson, James R., Sanger, Warren G.

“…Primary CD30(Ki-1)-positive anaplastic large-call lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5)…”
Get full text

2020 Is 18F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer 14C-EF3 in animal tumour models by Christian, N, Deheneffe, S, Bol, A, De Bast, M, Labar, D, Lee, J.A, Gregoire, V

Get full text

Lymphomatous polyposis : A neoplasm of either follicular mantle or germinal center cell origin by MOYNIHAN, M. J, BAST, M. A, CHAN, W. C, DELABIE, J, WICKERT, R. S, GUANQING WU, WEISENBURGER, D. D

“…Lymphomatous polyposis (LP) is generally thought to be an expression of non-Hodgkin's lymphoma (NHL) of follicular mantle cell (MC) origin. We report nine…”
Get full text

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project by Perry, Anamarija M, Diebold, Jacques, Nathwani, Bharat N, MacLennan, Kenneth A, Müller-Hermelink, Hans K, Bast, Martin, Boilesen, Eugene, Armitage, James O, Weisenburger, Dennis D

“…The distribution of non-Hodgkin lymphoma subtypes varies around the world, but a large systematic comparative study has never been done. In this study, we…”
Get full text

A review on continuous biomass hydrothermal liquefaction systems: Process design and operating parameters effects on biocrude by El Bast, M., Allam, N., Abou Msallem, Y., Awad, S., Loubar, K.

“…In the era of limited energy resources, researchers and scientists are highlighting bioenergy or biomass energy as a sustainable form of renewable and…”
Get full text